Eric M. Attias, Managing Partner and Co-Founder of Forepont Capital Partners. See sector focus and contact routes.
Eric M. Attias, Managing Partner and Co-Founder of Forepont Capital Partners, invests in early-to-growth-stage (Series A and B) biotech, medtech, life sciences, and digital-health startups in the United States and Europe, with average check sizes of $5 million and re-investment capacity up to $10 million. His distinctive thesis employs a hybrid philanthropy-investment model that funds basic medical research—particularly in neurology—before providing equity to the resulting commercial ventures, while donating 10% of firm revenues to the Neurogen Research foundation. Notable portfolio companies include French biotechs BioSpeedia, BayBridgeDigital (which received a $6 million Series A led by Forepont), Basecamp Vascular, and Exeliom Biosciences, as well as therapeutic devices firm Precision Neuroscience.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Eric M. Attias · Full investor directory · Investor access · Company funding database